Otávio Rizzi Coelho

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease

Thiago Ferreira de Souza, Thiago Quinaglia, Felipe Osório Costa et al. · JACC. Cardiovascular imaging · 2018 · 149 citations · Full text

Cardiomyopathy, Heart Failure, Structural Heart Disease +13

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

Andrei C. Spósito, Antônio de Pádua Mansur, Otávio Rizzi Coelho et al. · The American Journal of Cardiology · 1999 · 140 citations

Hypertension, Hypercholesterolemic Patients, Cardiovascular Disease +10

Effect of Spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

Félix José Alvarez Ramires, Antônio de Pádua Mansur, Otávio Rizzi Coelho et al. · The American Journal of Cardiology · 2000 · 128 citations

Ventricular Arrhythmias, Heart Failure, Cardiomyopathy +8

Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease—A randomized placebo-controlled study

Juliano Lara Fernandes, Rômulo Tadeu Dias de Oliveira, Ronei Luciano Mamoni et al. · Atherosclerosis · 2006 · 106 citations

Inflammation, Anti-inflammatory, Cardiovascular Disease +9